COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics | COMM | 00461U105 | 3,097 | 1,911,573 | SH | | SOLE | | 1,911,573 | 0 | 0 |
Akouos, Inc | ADR | 00973J101 | 34,089 | 1,515,073 | SH | | SOLE | | 1,515,073 | 0 | 0 |
Amarin | ADR | 023111206 | 36,041 | 5,208,305 | SH | | SOLE | | 5,208,305 | 0 | 0 |
Apellis Pharmaceuticals, Inc | COMM | 03753U106 | 1,619 | 49,580 | SH | | SOLE | | 49,580 | 0 | 0 |
Ascendis Pharma A/S | ADR | 04351P101 | 164,150 | 1,109,874 | SH | | SOLE | | 1,109,874 | 0 | 0 |
Chiasma | COMM | 16706W102 | 8,771 | 1,630,221 | SH | | SOLE | | 1,630,221 | 0 | 0 |
Coherus BioSciences | COMM | 19249H103 | 34,527 | 1,933,221 | SH | | SOLE | | 1,933,221 | 0 | 0 |
Entasis Therapeutics Holdings Inc. | COMM | 293614103 | 3,493 | 1,180,178 | SH | | SOLE | | 1,180,178 | 0 | 0 |
Galera Therapeutics, Inc | COMM | 36338D108 | 22,018 | 3,083,712 | SH | | SOLE | | 3,083,712 | 0 | 0 |
Karuna Therapeutics, Inc. | COMM | 48576A100 | 210,169 | 1,885,602 | SH | | SOLE | | 1,885,602 | 0 | 0 |
Kiniksa Pharmaceuticals, Ltd | COMM CL A | G5269C101 | 20,634 | 809,803 | SH | | SOLE | | 809,803 | 0 | 0 |
Merus N.V. | COMM | N5749R100 | 21,095 | 1,311,039 | SH | | SOLE | | 1,311,039 | 0 | 0 |
Natera | COMM | 632307104 | 154,594 | 3,100,560 | SH | | SOLE | | 3,100,560 | 0 | 0 |
Nextcure, Inc | COMM | 65343E108 | 57,285 | 2,671,856 | SH | | SOLE | | 2,671,856 | 0 | 0 |
Nucana Biomed Ltd | ADR | 67022C106 | 12,263 | 2,266,666 | SH | | SOLE | | 2,266,666 | 0 | 0 |
Nucana Biomed Ltd | Ordinary Shares | GBOOBYWYV | 12,984 | 2,400,000 | SH | | SOLE | | 2,400,000 | 0 | 0 |
ObsEva SA | COMM | H5861P103 | 27,975 | 4,749,623 | SH | | SOLE | | 4,749,623 | 0 | 0 |
PDS Biotechnology Corporation | COMM | 70465T107 | 287 | 142,635 | SH | | SOLE | | 142,635 | 0 | 0 |
Principia Biopharma | COMM | 74257L108 | 84,738 | 1,417,258 | SH | | SOLE | | 1,417,258 | 0 | 0 |
Synlogic Inc. | COMM | 87166L100 | 1,167 | 574,972 | SH | | SOLE | | 574,972 | 0 | 0 |
Y-mAbs Therapeutics, Inc | COMM | 984241109 | 94,793 | 2,194,278 | SH | | SOLE | | 2,194,278 | 0 | 0 |
Abbvie Inc | COMM | 00287Y109 | 10,772 | 109,717 | SH | | SOLE | | 109,717 | 0 | 0 |
Acceleron Pharma Inc | COMM | 00434H108 | 9,016 | 94,641 | SH | | SOLE | | 94,641 | 0 | 0 |
Akebia Therapeutics Inc | COMM | 00972D105 | 4,032 | 296,912 | SH | | SOLE | | 296,912 | 0 | 0 |
Alnylam Pharmaceuticals Inc | COMM | 02043Q907 | 9,672 | 65,300 | SH | Call | SOLE | | 65,300 | 0 | 0 |
Amgen Inc | COMM | 031162950 | 17,336 | 73,500 | SH | Put | SOLE | | 73,500 | 0 | 0 |
Applied Genetic Technologies Corp | COMM | 03820J100 | 2,582 | 466,103 | SH | | SOLE | | 466,103 | 0 | 0 |
Arena Pharmaceuticals Inc | COMM | 040047607 | 382 | 6,065 | SH | | SOLE | | 6,065 | 0 | 0 |
Axsome Therapeutics Inc | COMM | 05464T104 | 3,116 | 37,871 | SH | | SOLE | | 37,871 | 0 | 0 |
BioCryst Pharmaceuticals Inc | COMM | 09058V103 | 2,821 | 592,106 | SH | | SOLE | | 592,106 | 0 | 0 |
Biomarin Pharmaceutical Inc | COMM | 09061G101 | 3,378 | 27,390 | SH | | SOLE | | 27,390 | 0 | 0 |
Blueprint Medicines Corp | COMM | 09627Y109 | 3,231 | 41,427 | SH | | SOLE | | 41,427 | 0 | 0 |
Calithera Biosciences Inc | COMM | 13089P101 | 2,092 | 396,177 | SH | | SOLE | | 396,177 | 0 | 0 |
ChemoCentryx Inc | COMM | 16383L106 | 2,428 | 42,192 | SH | | SOLE | | 42,192 | 0 | 0 |
Compugen Ltd | COMM | M25722105 | 678 | 45,107 | SH | | SOLE | | 45,107 | 0 | 0 |
Constellation Pharmaceuticals Inc | COMM | 210373106 | 2,709 | 90,144 | SH | | SOLE | | 90,144 | 0 | 0 |
Cytokinetics Inc | COMM | 23282W605 | 1,644 | 69,767 | SH | | SOLE | | 69,767 | 0 | 0 |
Eli Lilly & Co | COMM | 532457108 | 10,644 | 64,834 | SH | | SOLE | | 64,834 | 0 | 0 |
Gilead Sciences Inc | COMM | 375558103 | 13,519 | 175,706 | SH | | SOLE | | 175,706 | 0 | 0 |
SPDR Ser Tr | S&P Biotech | 81369Y959 | 6,535 | 65,300 | SH | Put | SOLE | | 65,300 | 0 | 0 |
Homology Medicines Inc | COMM | 438083107 | 2,185 | 143,831 | SH | | SOLE | | 143,831 | 0 | 0 |
Horizon Therapeutics PLC | COMM | G46188101 | 6,120 | 110,120 | SH | | SOLE | | 110,120 | 0 | 0 |
Immunovant Inc | COMM | 45258J102 | 447 | 18,338 | SH | | SOLE | | 18,338 | 0 | 0 |
Insmed Inc | COMM | 457669307 | 5,801 | 210,646 | SH | | SOLE | | 210,646 | 0 | 0 |
Intellia Therapeutics Inc | COMM | 45826J105 | 527 | 25,050 | SH | | SOLE | | 25,050 | 0 | 0 |
Intra-Cellular Therapies Inc | COMM | 46116X101 | 2,704 | 105,346 | SH | | SOLE | | 105,346 | 0 | 0 |
Intra-Cellular Therapies Inc | COMM | 46116X951 | 2,462 | 95,900 | SH | Put | SOLE | | 95,900 | 0 | 0 |
Invesco QQQ Trust | UNIT SER 1 | 46090E953 | 3,244 | 13,100 | SH | Put | SOLE | | 13,100 | 0 | 0 |
Jazz Pharmaceuticals PLC | COMM | G50871105 | 11,693 | 105,975 | SH | | SOLE | | 105,975 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 3,412 | 666,381 | SH | | SOLE | | 666,381 | 0 | 0 |
Kala Pharmaceuticals Inc | COMM | 483119103 | 2,319 | 220,610 | SH | | SOLE | | 220,610 | 0 | 0 |
Kura Oncology Inc | COMM | 50127T109 | 4,337 | 266,058 | SH | | SOLE | | 266,058 | 0 | 0 |
Liquidia Technologies Inc | COMM | 53635D202 | 2,933 | 348,305 | SH | | SOLE | | 348,305 | 0 | 0 |
Menlo Therapeutics Inc | COMM | 586858102 | 547 | 316,027 | SH | | SOLE | | 316,027 | 0 | 0 |
Merck & Co Inc | COMM | 58933Y105 | 15,233 | 196,985 | SH | | SOLE | | 196,985 | 0 | 0 |
Mersana Therapeutics Inc | COMM | 59045L106 | 1,408 | 60,184 | SH | | SOLE | | 60,184 | 0 | 0 |
Mirati Therapeutics Inc | COMM | 60468T105 | 401 | 3,514 | SH | | SOLE | | 3,514 | 0 | 0 |
Mirum Pharmaceuticals Inc | COMM | 604749101 | 4,590 | 235,882 | SH | | SOLE | | 235,882 | 0 | 0 |
MyoKardia Inc | COMM | 62857M105 | 4,718 | 48,826 | SH | | SOLE | | 48,826 | 0 | 0 |
Novocure Ltd | COMM | G6674U908 | 1,293 | 21,800 | SH | Call | SOLE | | 21,800 | 0 | 0 |
Oric Pharmaceuticals Inc | COMM | 68622P109 | 255 | 7,569 | SH | | SOLE | | 7,569 | 0 | 0 |
Otonomy Inc | COMM | 68906L105 | 2,672 | 738,154 | SH | | SOLE | | 738,154 | 0 | 0 |
PTC Therapeutics Inc | COMM | 69366J200 | 9,710 | 191,358 | SH | | SOLE | | 191,358 | 0 | 0 |
PTC Therapeutics Inc | COMM | 69366J900 | 1,324 | 26,100 | SH | Call | SOLE | | 26,100 | 0 | 0 |
Pfizer Inc | COMM | 717081903 | 2,492 | 76,200 | SH | Call | SOLE | | 76,200 | 0 | 0 |
Protagonist Therapeutics Inc | COMM | 74366E102 | 2,508 | 142,020 | SH | | SOLE | | 142,020 | 0 | 0 |
Puma Biotechnology Inc | COMM | 74587V107 | 5,427 | 520,370 | SH | | SOLE | | 520,370 | 0 | 0 |
Reata Pharmaceuticals Inc | COMM | 75615P103 | 886 | 5,680 | SH | | SOLE | | 5,680 | 0 | 0 |
Rigel Pharmaceuticals Inc | COMM | 766559603 | 271 | 147,828 | SH | | SOLE | | 147,828 | 0 | 0 |
SPDR Ser Tr | S&P Biotech | 78464A950 | 7,310 | 65,300 | SH | Put | SOLE | | 65,300 | 0 | 0 |
Supernus Pharmaceuticals Inc | COMM | 868459108 | 4,959 | 208,815 | SH | | SOLE | | 208,815 | 0 | 0 |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 601 | 40,583 | SH | | SOLE | | 40,583 | 0 | 0 |
TG Therapeutics Inc | COMM | 88322Q108 | 5,910 | 303,374 | SH | | SOLE | | 303,374 | 0 | 0 |
United Therapeutics Corp | COMM | 91307C102 | 16,048 | 132,624 | SH | | SOLE | | 132,624 | 0 | 0 |
Zymeworks Inc | COMM | 98985W102 | 4,394 | 121,815 | SH | | SOLE | | 121,815 | 0 | 0 |
iShares Tr | Russell 2000 ETF | 464287955 | 4,367 | 30,500 | SH | Put | SOLE | | 30,500 | 0 | 0 |
Abbvie Inc | COMM | 00287Y109 | 4,067 | 41,422 | SH | | OTR | 1 | 41,422 | 0 | 0 |
Acceleron Pharma Inc | COMM | 00434H108 | 3,408 | 35,774 | SH | | OTR | 1 | 35,774 | 0 | 0 |
Akebia Therapeutics Inc | COMM | 00972D105 | 1,525 | 112,262 | SH | | OTR | 1 | 112,262 | 0 | 0 |
Alnylam Pharmaceuticals Inc | COMM | 02043Q907 | 3,658 | 24,700 | SH | Call | OTR | 1 | 24,700 | 0 | 0 |
Amgen Inc | COMM | 031162950 | 6,510 | 27,600 | SH | Put | OTR | 1 | 27,600 | 0 | 0 |
Applied Genetic Technologies Corp | COMM | 03820J100 | 973 | 175,613 | SH | | OTR | 1 | 175,613 | 0 | 0 |
Arena Pharmaceuticals Inc | COMM | 040047607 | 144 | 2,292 | SH | | OTR | 1 | 2,292 | 0 | 0 |
Axsome Therapeutics Inc | COMM | 05464T104 | 1,178 | 14,319 | SH | | OTR | 1 | 14,319 | 0 | 0 |
BioCryst Pharmaceuticals Inc | COMM | 09058V103 | 1,063 | 223,133 | SH | | OTR | 1 | 223,133 | 0 | 0 |
Biomarin Pharmaceutical Inc | COMM | 09061G101 | 1,275 | 10,340 | SH | | OTR | 1 | 10,340 | 0 | 0 |
Blueprint Medicines Corp | COMM | 09627Y109 | 1,217 | 15,607 | SH | | OTR | 1 | 15,607 | 0 | 0 |
Calithera Biosciences Inc | COMM | 13089P101 | 787 | 149,096 | SH | | OTR | 1 | 149,096 | 0 | 0 |
ChemoCentryx Inc | COMM | 16383L106 | 918 | 15,954 | SH | | OTR | 1 | 15,954 | 0 | 0 |
Compugen Ltd | COMM | M25722105 | 256 | 17,030 | SH | | OTR | 1 | 17,030 | 0 | 0 |
Constellation Pharmaceuticals Inc | COMM | 210373106 | 1,024 | 34,077 | SH | | OTR | 1 | 34,077 | 0 | 0 |
Cytokinetics Inc | COMM | 23282W605 | 621 | 26,340 | SH | | OTR | 1 | 26,340 | 0 | 0 |
Eli Lilly & Co | COMM | 532457108 | 4,021 | 24,493 | SH | | OTR | 1 | 24,493 | 0 | 0 |
Gilead Sciences Inc | COMM | 375558103 | 5,104 | 66,335 | SH | | OTR | 1 | 66,335 | 0 | 0 |
Select Sector SPDR Tr | SBI Healthcare | 81369Y959 | 2,472 | 24,700 | SH | Put | OTR | 1 | 24,700 | 0 | 0 |
Homology Medicines Inc | COMM | 438083107 | 826 | 54,376 | SH | | OTR | 1 | 54,376 | 0 | 0 |
Horizon Therapeutics PLC | COMM | G46188101 | 2,314 | 41,630 | SH | | OTR | 1 | 41,630 | 0 | 0 |
Immunovant Inc | COMM | 45258J102 | 168 | 6,900 | SH | | OTR | 1 | 6,900 | 0 | 0 |
Insmed Inc | COMM | 457669307 | 2,193 | 79,643 | SH | | OTR | 1 | 79,643 | 0 | 0 |
Intellia Therapeutics Inc | COMM | 45826J105 | 199 | 9,459 | SH | | OTR | 1 | 9,459 | 0 | 0 |
Intra-Cellular Therapies Inc | COMM | 46116X951 | 929 | 36,200 | SH | Put | OTR | 1 | 36,200 | 0 | 0 |
Intra-Cellular Therapies Inc | COMM | 46116X101 | 1,021 | 39,793 | SH | | OTR | 1 | 39,793 | 0 | 0 |
Invesco QQQ Trust | UNIT SER 1 | 46090E953 | 1,213 | 4,900 | SH | Put | OTR | 1 | 4,900 | 0 | 0 |
Jazz Pharmaceuticals PLC | COMM | G50871105 | 4,417 | 40,035 | SH | | OTR | 1 | 40,035 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 1,290 | 251,920 | SH | | OTR | 1 | 251,920 | 0 | 0 |
Kala Pharmaceuticals Inc | COMM | 483119103 | 876 | 83,359 | SH | | OTR | 1 | 83,359 | 0 | 0 |
Kura Oncology Inc | COMM | 50127T109 | 1,637 | 100,445 | SH | | OTR | 1 | 100,445 | 0 | 0 |
Liquidia Technologies Inc | COMM | 53635D202 | 1,109 | 131,694 | SH | | OTR | 1 | 131,694 | 0 | 0 |
Menlo Therapeutics Inc | COMM | 586858102 | 207 | 119,406 | SH | | OTR | 1 | 119,406 | 0 | 0 |
Merck & Co Inc | COMM | 58933Y105 | 5,739 | 74,217 | SH | | OTR | 1 | 74,217 | 0 | 0 |
Mersana Therapeutics Inc | COMM | 59045L106 | 531 | 22,681 | SH | | OTR | 1 | 22,681 | 0 | 0 |
Mirati Therapeutics Inc | COMM | 60468T105 | 152 | 1,328 | SH | | OTR | 1 | 1,328 | 0 | 0 |
Mirum Pharmaceuticals Inc | COMM | 604749101 | 1,735 | 89,150 | SH | | OTR | 1 | 89,150 | 0 | 0 |
MyoKardia Inc | COMM | 62857M105 | 1,776 | 18,385 | SH | | OTR | 1 | 18,385 | 0 | 0 |
Novocure Ltd | COMM | G6674U908 | 486 | 8,200 | SH | Call | OTR | 1 | 8,200 | 0 | 0 |
Oric Pharmaceuticals Inc | COMM | 68622P109 | 96 | 2,858 | SH | | OTR | 1 | 2,858 | 0 | 0 |
Otonomy Inc | COMM | 68906L105 | 1,028 | 283,853 | SH | | OTR | 1 | 283,853 | 0 | 0 |
PTC Therapeutics Inc | COMM | 69366J200 | 3,658 | 72,085 | SH | | OTR | 1 | 72,085 | 0 | 0 |
PTC Therapeutics Inc | COMM | 69366J900 | 502 | 9,900 | SH | Call | OTR | 1 | 9,900 | 0 | 0 |
Pfizer Inc | COMM | 717081903 | 942 | 28,800 | SH | Call | OTR | 1 | 28,800 | 0 | 0 |
Protagonist Therapeutics Inc | COMM | 74366E102 | 947 | 53,626 | SH | | OTR | 1 | 53,626 | 0 | 0 |
Puma Biotechnology Inc | COMM | 74587V107 | 2,055 | 196,982 | SH | | OTR | 1 | 196,982 | 0 | 0 |
Reata Pharmaceuticals Inc | COMM | 75615P103 | 335 | 2,146 | SH | | OTR | 1 | 2,146 | 0 | 0 |
Rigel Pharmaceuticals Inc | COMM | 766559603 | 102 | 55,898 | SH | | OTR | 1 | 55,898 | 0 | 0 |
SPDR Ser Tr | S&P Biotech | 78464A950 | 2,765 | 24,700 | SH | Put | OTR | 1 | 24,700 | 0 | 0 |
Supernus Pharmaceuticals Inc | COMM | 868459108 | 1,868 | 78,672 | SH | | OTR | 1 | 78,672 | 0 | 0 |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 227 | 15,286 | SH | | OTR | 1 | 15,286 | 0 | 0 |
TG Therapeutics Inc | COMM | 88322Q108 | 2,233 | 114,646 | SH | | OTR | 1 | 114,646 | 0 | 0 |
United Therapeutics Corp | COMM | 91307C102 | 6,066 | 50,133 | SH | | OTR | 1 | 50,133 | 0 | 0 |
Zymeworks Inc | COMM | 98985W102 | 1,654 | 45,848 | SH | | OTR | 1 | 45,848 | 0 | 0 |
iShares Tr | Russell 2000 ETF | 464287955 | 1,647 | 11,500 | SH | Put | OTR | 1 | 11,500 | 0 | 0 |
Abbvie Inc | COMM | 00287Y109 | 9,899 | 100,820 | SH | | OTR | 2 | 100,820 | 0 | 0 |
Acceleron Pharma Inc | COMM | 00434H108 | 8,286 | 86,975 | SH | | OTR | 2 | 86,975 | 0 | 0 |
Akebia Therapeutics Inc | COMM | 00972D105 | 3,704 | 272,718 | SH | | OTR | 2 | 272,718 | 0 | 0 |
Alnylam Pharmaceuticals Inc | COMM | 02043Q907 | 8,887 | 60,000 | SH | Call | OTR | 2 | 60,000 | 0 | 0 |
Amgen Inc | COMM | 031162950 | 15,897 | 67,400 | SH | Put | OTR | 2 | 67,400 | 0 | 0 |
Applied Genetic Technologies Corp | COMM | 03820J100 | 2,790 | 503,538 | SH | | OTR | 2 | 503,538 | 0 | 0 |
Arena Pharmaceuticals Inc | COMM | 040047607 | 351 | 5,572 | SH | | OTR | 2 | 5,572 | 0 | 0 |
Axsome Therapeutics Inc | COMM | 05464T104 | 2,862 | 34,788 | SH | | OTR | 2 | 34,788 | 0 | 0 |
BioCryst Pharmaceuticals Inc | COMM | 09058V103 | 2,586 | 542,609 | SH | | OTR | 2 | 542,609 | 0 | 0 |
Biomarin Pharmaceutical Inc | COMM | 09061G101 | 3,104 | 25,167 | SH | | OTR | 2 | 25,167 | 0 | 0 |
Blueprint Medicines Corp | COMM | 09627Y109 | 2,953 | 37,857 | SH | | OTR | 2 | 37,857 | 0 | 0 |
Calithera Biosciences Inc | COMM | 13089P101 | 2,614 | 495,126 | SH | | OTR | 2 | 495,126 | 0 | 0 |
ChemoCentryx Inc | COMM | 16383L106 | 2,231 | 38,770 | SH | | OTR | 2 | 38,770 | 0 | 0 |
Compugen Ltd | COMM | M25722105 | 623 | 41,450 | SH | | OTR | 2 | 41,450 | 0 | 0 |
Constellation Pharmaceuticals Inc | COMM | 210373106 | 2,490 | 82,866 | SH | | OTR | 2 | 82,866 | 0 | 0 |
Cytokinetics Inc | COMM | 23282W605 | 1,511 | 64,110 | SH | | OTR | 2 | 64,110 | 0 | 0 |
Eli Lilly & Co | COMM | 532457108 | 9,781 | 59,573 | SH | | OTR | 2 | 59,573 | 0 | 0 |
Gilead Sciences Inc | COMM | 375558103 | 12,422 | 161,453 | SH | | OTR | 2 | 161,453 | 0 | 0 |
Select Sector SPDR Tr | SBI Healthcare | 81369Y959 | 6,004 | 60,000 | SH | Put | OTR | 2 | 60,000 | 0 | 0 |
Homology Medicines Inc | COMM | 438083107 | 2,223 | 146,372 | SH | | OTR | 2 | 146,372 | 0 | 0 |
Horizon Therapeutics PLC | COMM | G46188101 | 5,625 | 101,208 | SH | | OTR | 2 | 101,208 | 0 | 0 |
Immunovant Inc | COMM | 45258J102 | 372 | 15,275 | SH | | OTR | 2 | 15,275 | 0 | 0 |
Insmed Inc | COMM | 457669307 | 5,334 | 193,678 | SH | | OTR | 2 | 193,678 | 0 | 0 |
Intellia Therapeutics Inc | COMM | 45826J105 | 483 | 22,991 | SH | | OTR | 2 | 22,991 | 0 | 0 |
Intra-Cellular Therapies Inc | COMM | 46116X951 | 2,256 | 87,900 | SH | Put | OTR | 2 | 87,900 | 0 | 0 |
Intra-Cellular Therapies Inc | COMM | 46116X101 | 2,484 | 96,769 | SH | | OTR | 2 | 96,769 | 0 | 0 |
Invesco QQQ Trust | UNIT SER 1 | 46090E953 | 2,971 | 12,000 | SH | Put | OTR | 2 | 12,000 | 0 | 0 |
Jazz Pharmaceuticals PLC | COMM | G50871105 | 10,741 | 97,343 | SH | | OTR | 2 | 97,343 | 0 | 0 |
Kadmon Holdings Inc | COMM | 48283N106 | 3,136 | 612,563 | SH | | OTR | 2 | 612,563 | 0 | 0 |
Kala Pharmaceuticals Inc | COMM | 483119103 | 2,130 | 202,678 | SH | | OTR | 2 | 202,678 | 0 | 0 |
Kura Oncology Inc | COMM | 50127T109 | 3,985 | 244,476 | SH | | OTR | 2 | 244,476 | 0 | 0 |
Liquidia Technologies Inc | COMM | 53635D202 | 2,694 | 320,001 | SH | | OTR | 2 | 320,001 | 0 | 0 |
Menlo Therapeutics Inc | COMM | 586858102 | 502 | 290,138 | SH | | OTR | 2 | 290,138 | 0 | 0 |
Merck & Co Inc | COMM | 58933Y105 | 13,918 | 179,976 | SH | | OTR | 2 | 179,976 | 0 | 0 |
Mersana Therapeutics Inc | COMM | 59045L106 | 1,289 | 55,101 | SH | | OTR | 2 | 55,101 | 0 | 0 |
Mirati Therapeutics Inc | COMM | 60468T105 | 369 | 3,230 | SH | | OTR | 2 | 3,230 | 0 | 0 |
Mirum Pharmaceuticals Inc | COMM | 604749101 | 4,216 | 216,669 | SH | | OTR | 2 | 216,669 | 0 | 0 |
MyoKardia Inc | COMM | 62857M105 | 4,309 | 44,599 | SH | | OTR | 2 | 44,599 | 0 | 0 |
Novocure Ltd | COMM | G6674U908 | 1,186 | 20,000 | SH | Call | OTR | 2 | 20,000 | 0 | 0 |
Oric Pharmaceuticals Inc | COMM | 68622P109 | 234 | 6,942 | SH | | OTR | 2 | 6,942 | 0 | 0 |
Otonomy Inc | COMM | 68906L105 | 2,278 | 629,404 | SH | | OTR | 2 | 629,404 | 0 | 0 |
PTC Therapeutics Inc | COMM | 69366J200 | 8,871 | 174,827 | SH | | OTR | 2 | 174,827 | 0 | 0 |
PTC Therapeutics Inc | COMM | 69366J900 | 1,218 | 24,000 | SH | Call | OTR | 2 | 24,000 | 0 | 0 |
Pfizer Inc | COMM | 717081903 | 2,289 | 70,000 | SH | Call | OTR | 2 | 70,000 | 0 | 0 |
Protagonist Therapeutics Inc | COMM | 74366E102 | 2,303 | 130,418 | SH | | OTR | 2 | 130,418 | 0 | 0 |
Puma Biotechnology Inc | COMM | 74587V107 | 5,009 | 480,278 | SH | | OTR | 2 | 480,278 | 0 | 0 |
Reata Pharmaceuticals Inc | COMM | 75615P103 | 813 | 5,209 | SH | | OTR | 2 | 5,209 | 0 | 0 |
Rigel Pharmaceuticals Inc | COMM | 766559603 | 249 | 135,969 | SH | | OTR | 2 | 135,969 | 0 | 0 |
SPDR Ser Tr | S&P Biotech | 78464A950 | 6,717 | 60,000 | SH | Put | OTR | 2 | 60,000 | 0 | 0 |
Supernus Pharmaceuticals Inc | COMM | 868459108 | 4,532 | 190,842 | SH | | OTR | 2 | 190,842 | 0 | 0 |
Syndax Pharmaceuticals Inc | COMM | 87164F105 | 535 | 36,095 | SH | | OTR | 2 | 36,095 | 0 | 0 |
TG Therapeutics Inc | COMM | 88322Q108 | 5,423 | 278,370 | SH | | OTR | 2 | 278,370 | 0 | 0 |
United Therapeutics Corp | COMM | 91307C102 | 14,738 | 121,805 | SH | | OTR | 2 | 121,805 | 0 | 0 |
Zymeworks Inc | COMM | 98985W102 | 4,764 | 132,071 | SH | | OTR | 2 | 132,071 | 0 | 0 |
iShares Tr | Russell 2000 ETF | 464287955 | 4,009 | 28,000 | SH | Put | OTR | 2 | 28,000 | 0 | 0 |